LiDCO Group plc (LON:LID)‘s stock had its “corporate” rating reiterated by equities research analysts at FinnCap in a report issued on Tuesday. They presently have a GBX 14 ($0.17) price objective on the stock. FinnCap’s target price would indicate a potential upside of 119.61% from the stock’s previous close.

Shares of LiDCO Group plc (LON:LID) opened at 6.05 on Tuesday. The company’s market cap is GBX 11.75 million. LiDCO Group plc has a 52-week low of GBX 5.25 and a 52-week high of GBX 11.20. The company has a 50 day moving average of GBX 6.15 and a 200-day moving average of GBX 7.02.

About LiDCO Group plc

LiDCO Group Plc is a United Kingdom-based supplier of non-invasive and minimally invasive hemodynamic monitoring equipment to hospitals. The Company is engaged in the development, manufacture and sale of cardiac monitoring equipment. It operates in the segment of supply of monitors, consumables and support services associated with the use of its cardiac monitoring equipment.

Receive News & Stock Ratings for LiDCO Group plc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LiDCO Group plc and related stocks with our FREE daily email newsletter.